🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Join us Tuesday, February 20th as Dr. Eden Miller and Dr. James Gavin discuss the past, present, and future of insulin delivery! Register for the webinar and Q&A here: bit.ly/3SR27I6

Curious how insulin pumps fit into the landscape of T2D therapy? Join embecta at #ATTD2024 to hear #diabetes care experts explore the value and utilization of insulin pumps for T2D, with the opportunity to engage in an audience Q&A session. Join us in Italy!

Kick off #ATTD2024 on March 6th at our Industry Symposium on the role of insulin pump therapy in #diabetes treatment.

We are looking forward to coming together with other #diabetes technology industry leaders at #ATTD2024 in Florence, Italy.

Tomorrow, these distinguished faculty will present new research on the potential of #insulin pump therapy for #T2D and the future of personalized #diabetes care at our #ATTD2024 Industry Symposium. Hope to see you there!

Today is the day! We're excited to start #ATTD2024 with our Industry Symposium. Join us for insights into exciting #diabetes technology research. Elevate your diabetes care knowledge with us today!

Join our second quarter fiscal year 2024 earnings call tomorrow at 8:00AM ET. Tune in here: investors.embecta.com.

Lunch is absorbing and insulin is flowing as #DiabetesMine founder Amy Tenderich gives the opening presentation to kick off #DData2024 Many thanks to the sponsors: Dexcom Eli Lilly and Company Omnipod embecta and MannKind

We’re proud to partner with embecta. Our deep expertise in the life sciences & healthcare sectors alongside our capabilities in data and technologies enables embecta’s vision to make a meaningful impact in the healthcare sector. bit.ly/4fsSLf5

We're looking forward to presenting at the 43rd annual J.P. Morgan Healthcare Conference. Read more about our participation at #JPM2025 in our release: investors.embecta.com/news-releases/…

Happy New Year 2025!

Come say hello to us tomorrow at #JPM2025! Our President and CEO Dev Kurdikar will be presenting at 7:30 a.m. PT / 10:30 a.m. ET. Not attending? Listen to the webcast here: bit.ly/4fWJOJJ

Earlier today, our President and CEO Dev Kurdikar presented at #JPM2025. Miss the live presentation? Check out his remarks here: bit.ly/4fWJOJJ

Join our First Quarter Fiscal Year 2025 earnings call tomorrow at 8:00AM ET. Tune in here: investors.embecta.com.

Today we hosted our First Quarter Fiscal Year 2025 earnings call. You can read the results in our press release here: bit.ly/3CIijGl

Are your patients with #diabetes staying vigilant about #kidneycare? These #WorldKidneyDay reminders can help them keep their kidney health top of mind.

Find your purpose supporting the #diabetes community by driving innovation in the field. Learn more about our open careers here: bit.ly/49AuOzu

Join our Second Quarter Fiscal Year 2025 earnings call tomorrow at 8:00AM ET. Tune in here: investors.embecta.com.

Today we hosted our Second Quarter Fiscal Year 2025 earnings call. You can read the results in our press release here: bit.ly/4jQ0AgC

We’re excited to host our inaugural Analyst and Investor Day on Thursday, May 22, to showcase our strategic vision and long-range financial plan. Register at investorday.embecta.com.